Holistic precision wellness: Paving the way for next-generation precision medicine (ngPM) with AI, biomedical informatics, and clinical medicine
Date
2025Metadata
Show full item recordAbstract
A "quiet revolution" in medicine has been taking place over the past two decades. There are two converging dynamic forces that have propelled precision medicine to the limelight, garnering wide public attention. The first driver is the realization that populations within a disease area can be stratified, thus developing therapies tailored to their specific needs, and the capability to identify these populations by analyzing large, diverse datasets. The second driver is technology advances in multi-omics approaches and applications (i.e., molecularly informed medicine) enabling a more comprehensive portrait of disease biology. This promises to not only accelerate the development of precision medicine processes but also presents challenges for healthcare professionals and health systems that are struggling to interconnect and integrate disparate data sources into a cohesive clinical strategy to the benefit of their patients. We coin here the term next-generation precision medicine (ngPM), which is bound to become conventional in the clinics sooner or later. Artificial intelligence (AI) and machine learning (ML) in healthcare have transformative potential and are a strategic response to today's challenges and tomorrow's opportunities. The chief challenges here are how well precision medicine (PM) permeates primary care to become a standard of care and drive toward precision wellness or precision lifestyle (ngPM), while ensuring access to care is feasible, streamlined, and routine. We present here a perspective that would harness the power of ngPM for precision wellness.
Collections
- Medicine Research [1794 items ]
Related items
Showing items related by title, author, creator and subject.
-
Patients' lived experiences with antineoplastic medicines for the management of malignant solid tumours: A systematic review.
Brincat, Alison; Bonanno, Patricia Vella; Stewart, Derek; Weidmann, Anita E ( Elsevier , 2020 , Article)Antineoplastic medicines affect the patients' physical and psychosocial well-being posing challenges for patients, caregivers and healthcare professionals. However, little is known about the patients' lived experience with ... -
Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: Surveys in Qatar and Lebanon
Abdel Rida N.; Mohamed Ibrahim M.I.; Babar Z.U.D. ( BioMed Central Ltd. , 2019 , Article)Background: Cardiovascular diseases are the leading cause of death in Lebanon and Qatar. When lifestyle modifications prove insufficient, medication becomes a cornerstone in controlling such diseases and saving lives. ... -
Monitoring the impact of regulatory measures on medicine pricing in Thailand: an observation over a 16-year span.
Sooksriwong, Chaoncin; Hirunrassamee, Sanita; Suwattanapreeda, Siriwat; Maluangnon, Kusawadee; Chuachantra, Thirapich; Babar, Zaheer-Ud-Din; Kuchaisit, Krissana; Osirisakul, Niti... more authors ... less authors ( Taylor and Francis Group , 2025 , Article)Following a 2007 report by the Thai Food and Drug Administration highlighting disparities in drug pricing across different sectors, there has been a concerted effort to establish and enforce a cohesive medicine pricing ...